RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

The current price doesn't assume CX717 is going to be usable for anything.

If I could get a good feeling that is true, I'd buy even more right now.

But if CX-717 gets shot down by the FDA in a few months, or it becomes obvious that Cortex would have to spend a lot more time and resources trying to get the FDA to liberalize CX-717's dosing limits, I think the stock price will take a significant hit. As a WAG, say a drop to .80

The reason (in spite of the above) that I added some COR last week was because if the FDA does kill CX-717 for ADHD, it likely forces Cortex into a licensing agreement that would be less than Cortex had hoped for, but which gets Ampakines under a BPs umbrella for development.

And that likely would have a favorable effect on the stock price.

So buying shares now yields a huge reward if the FDA gives a good decision on CX-717, but has limited downside if it forces Cortex into a BP deal since that should cause the pps to recover to at least its current level... Aiming4.